• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Quantification, self-renewal, and genetic tracing of FL1⁺ tumor-initiating cells in a large cohort of human gliomas.在一大群人类胶质瘤中对 FL1⁺ 肿瘤起始细胞进行定量、自我更新和遗传示踪。
Neuro Oncol. 2012 Jun;14(6):720-35. doi: 10.1093/neuonc/nos084. Epub 2012 May 14.
2
Marker-independent identification of glioma-initiating cells.无标志物鉴定神经胶质瘤起始细胞。
Nat Methods. 2010 Mar;7(3):224-8. doi: 10.1038/nmeth.1430. Epub 2010 Feb 21.
3
Mouse induced glioma-initiating cell models and therapeutic targets.鼠诱导的神经胶质瘤起始细胞模型和治疗靶点。
Anticancer Agents Med Chem. 2010 Jul;10(6):471-80. doi: 10.2174/1871520611009060471.
4
Isolation of glioma cancer stem cells in relation to histological grades in glioma specimens.胶质瘤标本中与组织学分级相关的胶质瘤癌干细胞的分离
Childs Nerv Syst. 2013 Feb;29(2):217-29. doi: 10.1007/s00381-012-1964-9. Epub 2012 Nov 10.
5
Clinical relevance of tumor cells with stem-like properties in pediatric brain tumors.具有类干细胞特性的肿瘤细胞在小儿脑肿瘤中的临床意义。
PLoS One. 2011 Jan 28;6(1):e16375. doi: 10.1371/journal.pone.0016375.
6
The cell of origin dictates the temporal course of neurofibromatosis-1 (Nf1) low-grade glioma formation.起源细胞决定了神经纤维瘤病1型(Nf1)低度胶质瘤形成的时间进程。
Oncotarget. 2017 Jul 18;8(29):47206-47215. doi: 10.18632/oncotarget.17589.
7
In vitro neurosphere formation correlates with poor survival in glioma.体外神经球形成与神经胶质瘤患者的不良预后相关。
IUBMB Life. 2019 Feb;71(2):244-253. doi: 10.1002/iub.1964. Epub 2018 Nov 4.
8
Development of a Sox2 reporter system modeling cellular heterogeneity in glioma.一种模拟胶质瘤细胞异质性的Sox2报告系统的开发。
Neuro Oncol. 2015 Mar;17(3):361-71. doi: 10.1093/neuonc/nou320. Epub 2014 Nov 21.
9
[Expression and significance of ABCG2 in human malignant glioma].ABCG2在人恶性胶质瘤中的表达及意义
Ai Zheng. 2007 Oct;26(10):1090-4.
10
The prognostic value of clinical factors and cancer stem cell-related markers in gliomas.临床因素和癌症干细胞相关标志物在胶质瘤中的预后价值。
Dan Med J. 2014 Oct;61(10):B4944.

本文引用的文献

1
In vivo metabolic profiling of glioma-initiating cells using proton magnetic resonance spectroscopy at 14.1 Tesla.在 14.1 特斯拉质子磁共振波谱仪下对神经胶质瘤起始细胞进行体内代谢组学分析。
NMR Biomed. 2012 Apr;25(4):506-13. doi: 10.1002/nbm.1763. Epub 2011 Jul 27.
2
Distinct germ line polymorphisms underlie glioma morphologic heterogeneity.独特的种系多态性是胶质瘤形态学异质性的基础。
Cancer Genet. 2011 Jan;204(1):13-8. doi: 10.1016/j.cancergencyto.2010.10.002.
3
The origins of glioma: E Pluribus Unum?胶质瘤的起源:多元归一?
Glia. 2011 Aug;59(8):1135-47. doi: 10.1002/glia.21143. Epub 2011 Feb 23.
4
The presence of stem cell marker-expressing cells is not prognostically significant in glioblastomas.在胶质母细胞瘤中,表达干细胞标志物的细胞的存在与预后无关。
Neuropathology. 2011 Oct;31(5):494-502. doi: 10.1111/j.1440-1789.2010.01194.x. Epub 2011 Jan 27.
5
Determination of somatic and cancer stem cell self-renewing symmetric division rate using sphere assays.利用球体培养实验测定体干细胞和肿瘤干细胞的自我更新对称分裂率。
PLoS One. 2011 Jan 5;6(1):e15844. doi: 10.1371/journal.pone.0015844.
6
Non-stem cell origin for oligodendroglioma.少突胶质细胞瘤的非干细胞起源。
Cancer Cell. 2010 Dec 14;18(6):669-82. doi: 10.1016/j.ccr.2010.10.033.
7
Cancer stem cells in the central nervous system--a critical review.中枢神经系统中的癌症干细胞——批判性综述。
Cancer Res. 2010 Nov 1;70(21):8255-8. doi: 10.1158/0008-5472.CAN-10-1592. Epub 2010 Oct 19.
8
Immune infiltration of spontaneous mouse astrocytomas is dominated by immunosuppressive cells from early stages of tumor development.自发型小鼠星形细胞瘤的免疫浸润主要由肿瘤发生早期的免疫抑制细胞所主导。
Cancer Res. 2010 Jun 15;70(12):4829-39. doi: 10.1158/0008-5472.CAN-09-3074. Epub 2010 May 25.
9
Glioma cell populations grouped by different cell type markers drive brain tumor growth.不同细胞类型标志物分组的神经胶质瘤细胞群促进脑肿瘤生长。
Cancer Res. 2010 Jun 1;70(11):4274-9. doi: 10.1158/0008-5472.CAN-09-3904. Epub 2010 May 11.
10
A hierarchy of self-renewing tumor-initiating cell types in glioblastoma.胶质母细胞瘤中自我更新肿瘤起始细胞类型的层次结构。
Cancer Cell. 2010 Apr 13;17(4):362-75. doi: 10.1016/j.ccr.2009.12.049.

在一大群人类胶质瘤中对 FL1⁺ 肿瘤起始细胞进行定量、自我更新和遗传示踪。

Quantification, self-renewal, and genetic tracing of FL1⁺ tumor-initiating cells in a large cohort of human gliomas.

机构信息

Department of Clinical Neurosciences, Service of Neurosurgery, Rue Gabrielle-Perret-Gentil, 4, CH-1211 Geneva, Switzerland.

出版信息

Neuro Oncol. 2012 Jun;14(6):720-35. doi: 10.1093/neuonc/nos084. Epub 2012 May 14.

DOI:10.1093/neuonc/nos084
PMID:22584872
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3367853/
Abstract

Evidence has emerged that the initiation and growth of gliomas is sustained by a subpopulation of cancer-initiating cells (CICs). Because of the difficulty of using markers to tag CICs in gliomas, we have previously exploited more robust phenotypic characteristics, including a specific morphology and intrincic autofluorescence, to identify and isolate a subpopulation of glioma CICs, called FL1(+). The objective of this study was to further validate our method in a large cohort of human glioma and a mouse model of glioma. Seventy-four human gliomas of all grades and the GFAP-V(12)HA-ras B8 mouse model were analyzed for in vitro self-renewal capacity and their content of FL1(+). Nonneoplastic brain tissue and embryonic mouse brain were used as control. Genetic traceability along passages was assessed with microsatellite analysis. We found that FL1(+) cells from low-grade gliomas and from control nonneoplasic brain tissue show a lower level of autofluorescence and undergo a restricted number of cell divisions before dying in culture. In contrast, we found that FL1(+) cells derived from many but not all high-grade gliomas acquire high levels of autofluorescence and can be propagated in long-term cultures. Moreover, FL1(+) cells show a remarkable traceability over time in vitro and in vivo. Our results show that FL1(+) cells can be found in all specimens of a large cohort of human gliomas of different grades and in a model of genetically induced mouse glioma as well as nonneoplastic brain. However, their self-renewal capacity is variable and seems to be dependent on the tumor grade.

摘要

有证据表明,神经胶质瘤的发生和生长是由一小部分癌起始细胞(CICs)维持的。由于使用标记物标记神经胶质瘤中的 CICs 存在困难,我们之前利用了更具特征性的表型特征,包括特定的形态和内在自发荧光,来鉴定和分离一小部分神经胶质瘤 CICs,称为 FL1(+)。本研究的目的是在一大群人类神经胶质瘤和神经胶质瘤的小鼠模型中进一步验证我们的方法。分析了 74 例不同分级的人类神经胶质瘤和 GFAP-V(12)HA-ras B8 小鼠模型,以评估其体外自我更新能力及其 FL1(+)含量。非肿瘤性脑组织和胚胎小鼠脑用作对照。通过微卫星分析评估遗传追踪在传代过程中的情况。我们发现,来自低级别神经胶质瘤和来自对照非肿瘤性脑组织的 FL1(+)细胞显示出较低的自发荧光水平,并在培养中死亡前经历有限的细胞分裂次数。相比之下,我们发现,许多(但不是所有)高级别神经胶质瘤衍生的 FL1(+)细胞获得高水平的自发荧光,并可在长期培养中增殖。此外,FL1(+)细胞在体外和体内具有显著的随时间推移的追踪能力。我们的结果表明,FL1(+)细胞可以在不同分级的一大群人类神经胶质瘤的所有标本以及遗传诱导的小鼠神经胶质瘤模型和非肿瘤性脑组织中找到。然而,它们的自我更新能力是可变的,似乎取决于肿瘤分级。